These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6144491)
21. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C]vigabatrin in healthy male volunteers. Durham SL; Hoke JF; Chen TM Drug Metab Dispos; 1993; 21(3):480-4. PubMed ID: 8100505 [TBL] [Abstract][Full Text] [Related]
23. The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites. de Jongh GD; van den Wildenberg HM; Nieuwenhuyse H; van der Veen F Drug Metab Dispos; 1981; 9(1):48-53. PubMed ID: 6111431 [TBL] [Abstract][Full Text] [Related]
24. Identification and measurement of urinary metabolites of afloqualone in man. Furuuchi S; Otsuka M; Miura Y; Harigaya S Drug Metab Dispos; 1983; 11(4):371-6. PubMed ID: 6137346 [TBL] [Abstract][Full Text] [Related]
25. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
26. Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid. Baba S; Osakabe N; Natsume M; Terao J Life Sci; 2004 May; 75(2):165-78. PubMed ID: 15120569 [TBL] [Abstract][Full Text] [Related]
27. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375 [TBL] [Abstract][Full Text] [Related]
28. Metabolic disposition of isoxicam in man, monkey, dog, and rat. Borondy PE; Michniewicz BM Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211 [TBL] [Abstract][Full Text] [Related]
29. Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids. Tseng YL; Sun CY; Kuo FH Steroids; 2006 Sep; 71(9):817-27. PubMed ID: 16814335 [TBL] [Abstract][Full Text] [Related]
30. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers. Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226 [TBL] [Abstract][Full Text] [Related]
31. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
32. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog. Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500 [TBL] [Abstract][Full Text] [Related]
33. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry. Bernauer U; Amberg A; Scheutzow D; Dekant W Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733 [TBL] [Abstract][Full Text] [Related]
34. Urinary metabolic profile of 19-norsteroids in humans: glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol. Torrado S; Roig M; Farré M; Segura J; Ventura R Rapid Commun Mass Spectrom; 2008 Oct; 22(19):3035-42. PubMed ID: 18763272 [TBL] [Abstract][Full Text] [Related]
35. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. Teichert J; Hermann R; Ruus P; Preiss R J Clin Pharmacol; 2003 Nov; 43(11):1257-67. PubMed ID: 14551180 [TBL] [Abstract][Full Text] [Related]
36. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905 [TBL] [Abstract][Full Text] [Related]
37. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Koch HM; Bolt HM; Preuss R; Angerer J Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144 [TBL] [Abstract][Full Text] [Related]
38. Gas chromatography/mass spectrometry characterization of urinary metabolites of danazol after oral administration in human. de Oca Porto RM; Fernández AR; Brito DM; Vidal TC; Diaz AL J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):178-83. PubMed ID: 16288903 [TBL] [Abstract][Full Text] [Related]
39. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans. Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226 [TBL] [Abstract][Full Text] [Related]
40. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]